世界のバイオ医薬品受託製造（BCMO）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0829 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、バイオ医薬品受託製造（BCMO）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（哺乳類ベース製造、微生物ベース製造、その他）、用途別市場規模（バイオ医薬品会社、製薬会社、創薬会社、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・バイオ医薬品受託製造（BCMO）の市場動向 ・企業の競争状況、市場シェア ・バイオ医薬品受託製造（BCMO）の種類別市場規模（哺乳類ベース製造、微生物ベース製造、その他） ・バイオ医薬品受託製造（BCMO）の用途別市場規模（バイオ医薬品会社、製薬会社、創薬会社、その他） ・バイオ医薬品受託製造（BCMO）の北米市場規模2016-2027（アメリカ、カナダ） ・バイオ医薬品受託製造（BCMO）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・バイオ医薬品受託製造（BCMO）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・バイオ医薬品受託製造（BCMO）の中南米市場規模2016-2027（メキシコ、ブラジル） ・バイオ医薬品受託製造（BCMO）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lonza Group Ltd、Boehringher Ingelheim、Sandoz、Fujifilm Diosynth Biotechnology、Rentschler Biotechnologie、Celonic GmbH、BIOMEVA GmbH、ProBioGen AG） ・結論

Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing(BCMO) Market
The global Biopharmaceutical Contract Manufacturing(BCMO) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical Contract Manufacturing(BCMO) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical Contract Manufacturing(BCMO) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical Contract Manufacturing(BCMO) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical Contract Manufacturing(BCMO) market.

Global Biopharmaceutical Contract Manufacturing(BCMO) Scope and Market Size
Biopharmaceutical Contract Manufacturing(BCMO) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing(BCMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mammalian Based Manufacturing
Microbial Based Manufacturing
Other

Segment by Application
Bio-Pharmaceutical Companies
Pharmaceutical Companies
Drug Discovery Companies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lonza Group Ltd
Boehringher Ingelheim
Sandoz
Fujifilm Diosynth Biotechnology
Rentschler Biotechnologie
Celonic GmbH
BIOMEVA GmbH
ProBioGen AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mammalian Based Manufacturing
1.2.3 Microbial Based Manufacturing
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bio-Pharmaceutical Companies
1.3.3 Pharmaceutical Companies
1.3.4 Drug Discovery Companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Perspective (2016-2027)
2.2 Biopharmaceutical Contract Manufacturing(BCMO) Growth Trends by Regions
2.2.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Share by Regions (2016-2021)
2.2.3 Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2022-2027)
2.3 Biopharmaceutical Contract Manufacturing(BCMO) Industry Dynamic
2.3.1 Biopharmaceutical Contract Manufacturing(BCMO) Market Trends
2.3.2 Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing(BCMO) Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Revenue (2016-2021)
3.1.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Players (2016-2021)
3.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing(BCMO) Revenue
3.4 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2020
3.5 Biopharmaceutical Contract Manufacturing(BCMO) Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing(BCMO) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Type (2016-2021)
4.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Type (2022-2027)

5 Biopharmaceutical Contract Manufacturing(BCMO) Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing(BCMO) Historic Market Size by Application (2016-2021)
5.2 Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027)
6.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type
6.2.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021)
6.2.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027)
6.2.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027)
6.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application
6.3.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021)
6.3.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027)
6.3.3 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027)
6.4 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
6.4.1 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021)
6.4.2 North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027)
7.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type
7.2.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021)
7.2.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027)
7.2.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027)
7.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application
7.3.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021)
7.3.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027)
7.3.3 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027)
7.4 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
7.4.1 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021)
7.4.2 Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027)
8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027)
9.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type
9.2.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021)
9.2.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027)
9.2.3 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027)
9.3 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application
9.3.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021)
9.3.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027)
9.3.3 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027)
9.4 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
9.4.1 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021)
9.4.2 Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size (2016-2027)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2027)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2027)
10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lonza Group Ltd
11.1.1 Lonza Group Ltd Company Details
11.1.2 Lonza Group Ltd Business Overview
11.1.3 Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.1.4 Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.1.5 Lonza Group Ltd Recent Development
11.2 Boehringher Ingelheim
11.2.1 Boehringher Ingelheim Company Details
11.2.2 Boehringher Ingelheim Business Overview
11.2.3 Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.2.4 Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.2.5 Boehringher Ingelheim Recent Development
11.3 Sandoz
11.3.1 Sandoz Company Details
11.3.2 Sandoz Business Overview
11.3.3 Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.3.4 Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.3.5 Sandoz Recent Development
11.4 Fujifilm Diosynth Biotechnology
11.4.1 Fujifilm Diosynth Biotechnology Company Details
11.4.2 Fujifilm Diosynth Biotechnology Business Overview
11.4.3 Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.4.4 Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.4.5 Fujifilm Diosynth Biotechnology Recent Development
11.5 Rentschler Biotechnologie
11.5.1 Rentschler Biotechnologie Company Details
11.5.2 Rentschler Biotechnologie Business Overview
11.5.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.5.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.5.5 Rentschler Biotechnologie Recent Development
11.6 Celonic GmbH
11.6.1 Celonic GmbH Company Details
11.6.2 Celonic GmbH Business Overview
11.6.3 Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.6.4 Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.6.5 Celonic GmbH Recent Development
11.7 BIOMEVA GmbH
11.7.1 BIOMEVA GmbH Company Details
11.7.2 BIOMEVA GmbH Business Overview
11.7.3 BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.7.4 BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.7.5 BIOMEVA GmbH Recent Development
11.8 ProBioGen AG
11.8.1 ProBioGen AG Company Details
11.8.2 ProBioGen AG Business Overview
11.8.3 ProBioGen AG Biopharmaceutical Contract Manufacturing(BCMO) Introduction
11.8.4 ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
11.8.5 ProBioGen AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mammalian Based Manufacturing
Table 3. Key Players of Microbial Based Manufacturing
Table 4. Key Players of Other
Table 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2016-2021)
Table 9. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2022-2027)
Table 11. Biopharmaceutical Contract Manufacturing(BCMO) Market Trends
Table 12. Biopharmaceutical Contract Manufacturing(BCMO) Market Drivers
Table 13. Biopharmaceutical Contract Manufacturing(BCMO) Market Challenges
Table 14. Biopharmaceutical Contract Manufacturing(BCMO) Market Restraints
Table 15. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Players (2016-2021)
Table 17. Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing(BCMO) as of 2020)
Table 18. Ranking of Global Top Biopharmaceutical Contract Manufacturing(BCMO) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing(BCMO) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biopharmaceutical Contract Manufacturing(BCMO) Product Solution and Service
Table 22. Date of Enter into Biopharmaceutical Contract Manufacturing(BCMO) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2016-2021)
Table 26. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application (2016-2021)
Table 30. Global Biopharmaceutical Contract Manufacturing(BCMO) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Lonza Group Ltd Company Details
Table 63. Lonza Group Ltd Business Overview
Table 64. Lonza Group Ltd Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 65. Lonza Group Ltd Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 66. Lonza Group Ltd Recent Development
Table 67. Boehringher Ingelheim Company Details
Table 68. Boehringher Ingelheim Business Overview
Table 69. Boehringher Ingelheim Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 70. Boehringher Ingelheim Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 71. Boehringher Ingelheim Recent Development
Table 72. Sandoz Company Details
Table 73. Sandoz Business Overview
Table 74. Sandoz Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 75. Sandoz Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 76. Sandoz Recent Development
Table 77. Fujifilm Diosynth Biotechnology Company Details
Table 78. Fujifilm Diosynth Biotechnology Business Overview
Table 79. Fujifilm Diosynth Biotechnology Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 80. Fujifilm Diosynth Biotechnology Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 81. Fujifilm Diosynth Biotechnology Recent Development
Table 82. Rentschler Biotechnologie Company Details
Table 83. Rentschler Biotechnologie Business Overview
Table 84. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 85. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 86. Rentschler Biotechnologie Recent Development
Table 87. Celonic GmbH Company Details
Table 88. Celonic GmbH Business Overview
Table 89. Celonic GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 90. Celonic GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 91. Celonic GmbH Recent Development
Table 92. BIOMEVA GmbH Company Details
Table 93. BIOMEVA GmbH Business Overview
Table 94. BIOMEVA GmbH Biopharmaceutical Contract Manufacturing(BCMO) Product
Table 95. BIOMEVA GmbH Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 96. BIOMEVA GmbH Recent Development
Table 97. ProBioGen AG Company Details
Table 98. ProBioGen AG Business Overview
Table 99. ProBioGen AG Revenue in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021) & (US$ Million)
Table 100. ProBioGen AG Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type: 2020 VS 2027
Figure 2. Mammalian Based Manufacturing Features
Figure 3. Microbial Based Manufacturing Features
Figure 4. Other Features
Figure 5. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application: 2020 VS 2027
Figure 6. Bio-Pharmaceutical Companies Case Studies
Figure 7. Pharmaceutical Companies Case Studies
Figure 8. Drug Discovery Companies Case Studies
Figure 9. Other Case Studies
Figure 10. Biopharmaceutical Contract Manufacturing(BCMO) Report Years Considered
Figure 11. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions: 2020 VS 2027
Figure 14. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Regions (2022-2027)
Figure 15. Global Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Players in 2020
Figure 16. Global Top Biopharmaceutical Contract Manufacturing(BCMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing(BCMO) as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing(BCMO) Revenue in 2020
Figure 18. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2016-2021)
Figure 19. Global Biopharmaceutical Contract Manufacturing(BCMO) Revenue Market Share by Type (2022-2027)
Figure 20. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027)
Figure 22. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027)
Figure 23. North America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027)
Figure 24. United States Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027)
Figure 28. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027)
Figure 29. Europe Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027)
Figure 30. Germany Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Region (2016-2027)
Figure 40. China Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027)
Figure 48. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027)
Figure 49. Latin America Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027)
Figure 50. Mexico Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Biopharmaceutical Contract Manufacturing(BCMO) Market Share by Country (2016-2027)
Figure 56. Turkey Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Biopharmaceutical Contract Manufacturing(BCMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Lonza Group Ltd Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 60. Boehringher Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 61. Sandoz Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 62. Fujifilm Diosynth Biotechnology Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 63. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 64. Celonic GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 65. BIOMEVA GmbH Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 66. ProBioGen AG Revenue Growth Rate in Biopharmaceutical Contract Manufacturing(BCMO) Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---